Holen Sie sich die Stockscreener-App
17.63
0.62%
-0.11
Schlusskurs vom Vortag:
$17.74
Offen:
$17.83
24-Stunden-Volumen:
289.08K
Relative Volume:
0.63
Marktkapitalisierung:
$950.42M
Einnahmen:
$2.22M
Nettoeinkommen (Verlust:
$-40.51M
KGV:
-13.72
EPS:
-1.2847
Netto-Cashflow:
$-46.53M
1W Leistung:
-6.87%
1M Leistung:
+64.00%
6M Leistung:
+120.93%
1J Leistung:
+0.00%
1-Tages-Spanne:
$17.54
$18.48
1-Wochen-Bereich:
$16.02
$19.37
52-Wochen-Spanne:
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
Firmenname
Upstream Bio Inc
Sektor
Branche
Telefon
781-208-2466
Adresse
890 WINTER STREET, SUITE 200, WALTHAM
Vergleichen Sie UPB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
17.63 | 971.45M | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Upstream Bio Inc Aktie (UPB) Neueste Nachrichten
Can Upstream Bio Inc. Outperform Peers After Recent PullbackQuarterly Earnings Report & Community Consensus Picks - newsyoung.net
Can trapped investors hope for a rebound in Upstream Bio Inc.2025 Market Sentiment & Short-Term High Return Ideas - Newser
Analyzing Upstream Bio Inc. with risk reward ratio charts2025 Trading Recap & Consistent Growth Stock Picks - Newser
Chart based exit strategy for Upstream Bio Inc.Earnings Performance Report & Weekly Stock Performance Updates - Newser
Upstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, Verekitug - MSN
Upstream Bio Inc. stock momentum explainedRate Hike & Daily Growth Stock Investment Tips - Newser
Upstream Bio Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
Analyzing recovery setups for Upstream Bio Inc. investorsJuly 2025 Retail & Daily Chart Pattern Signals - Newser
What to expect from Upstream Bio Inc. in the next 30 days2025 Momentum Check & Daily Price Action Insights - Newser
Short interest data insights for Upstream Bio Inc.2025 Technical Patterns & Real-Time Volume Analysis Alerts - Newser
Upstream Bio Inc. Charts Flash Early Recovery SignalsQuarterly Market Review & Consistent Profit Focused Trading Strategies - 선데이타임즈
Does Upstream Bio Inc. qualify in momentum factor screeningDividend Hike & AI Forecast for Swing Trade Picks - Newser
Watch for Trend Continuation in Upstream Bio Inc. Next WeekInflation Watch & Stepwise Swing Trade Plans - newsimpact.co.kr
How to use a screener to detect Upstream Bio Inc. breakoutsSwing Trade & Long-Term Safe Investment Ideas - Newser
Key resistance and support levels for Upstream Bio Inc.Entry Point & Expert Curated Trade Setup Alerts - Newser
Has Upstream Bio Inc. formed a bullish divergenceWeekly Trend Summary & High Return Trade Opportunity Guides - Newser
Analyzing net buyer seller activity in Upstream Bio Inc.Fed Meeting & Target Return Focused Stock Picks - Newser
Real time social sentiment graph for Upstream Bio Inc.Market Trend Report & Verified Stock Trade Ideas - Newser
Upstream Bio (UPB) Q2 R&D Soars 169% - AOL.com
Building trade automation scripts for Upstream Bio Inc.July 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
XTX Topco Ltd Takes $78,000 Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Real time breakdown of Upstream Bio Inc. stock performanceTreasury Yields & High Accuracy Trade Signal Alerts - Newser
Tools to assess Upstream Bio Inc.’s risk profileDollar Strength & Real-Time Volume Surge Alerts - Newser
Is it too late to sell Upstream Bio Inc.Trade Exit Summary & Safe Entry Zone Identification - Newser
Can Upstream Bio's (UPB) Rising Losses Outpace Revenue Growth in Its Long-Term Strategy? - simplywall.st
Ichimoku Cloud Indicates Uncertainty Around Upstream Bio Inc.July 2025 Volume & Reliable Entry Point Alerts - sundaytimes.kr
Upstream Bio Appoints Stacy Price as Chief Technology Officer - The Globe and Mail
Upstream Bio Inc. stock retracement – recovery analysisFree Reliable Chart-Based Trade Entries - Newser
Comparing Upstream Bio Inc. in custom built stock radarsFree Short Term Buy Zone Stock Alerts - Newser
What makes Upstream Bio Inc. stock price move sharplyForecasting Stock Moves with AI Insights - Newser
How Efficient Is Upstream Bio Inc. at Controlling Operating CostsChart Signal and Short-Term Forecast Tracker - Newser
Finanzdaten der Upstream Bio Inc-Aktie (UPB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Upstream Bio Inc-Aktie (UPB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Oct 15 '24 |
Buy |
17.00 |
825,000 |
14,025,000 |
4,554,873 |
| AI Upstream LLC | 10% Owner |
Oct 15 '24 |
Buy |
17.00 |
1,175,000 |
19,975,000 |
1,175,000 |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):